Schonfeld Strategic Advisors’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-171,114
| Closed | -$14.6M | – | 2032 |
|
|
2020
Q3 | $14.6M | Buy |
171,114
+146,219
| +587% | +$7.39M | 0.28% | 85 |
|
|
2020
Q2 | $882K | Buy |
24,895
+2,875
| +13% | +$84.1K | 0.02% | 635 |
|
|
2020
Q1 | $297K | Buy |
22,020
+3,607
| +20% | +$60.7K | 0.02% | 759 |
|
|
2019
Q4 | $390K | Sell |
18,413
-149,187
| -89% | -$2.63M | 0.01% | 848 |
|
|
2019
Q3 | $2.22M | Sell |
167,600
-118,500
| -41% | -$1.74M | 0.07% | 293 |
|
|
2019
Q2 | $3.97M | Buy |
286,100
+192,900
| +207% | +$2.9M | 0.14% | 176 |
|
|
2019
Q1 | $1.79M | Sell |
93,200
-272,157
| -74% | -$4.39M | 0.06% | 371 |
|
|
2018
Q4 | $5.21M | Buy |
+365,357
| New | +$7.25M | 0.2% | 137 |
|
|
2018
Q3 | – | Sell |
-35,900
| Closed | -$850K | – | 1107 |
|
|
2018
Q2 | $850K | Sell |
35,900
-234,367
| -87% | -$4.71M | 0.05% | 421 |
|
|
2018
Q1 | $3.95M | Buy |
270,267
+49,346
| +22% | +$806K | 0.3% | 98 |
|
|
2017
Q4 | $21K | Buy |
220,921
+198,388
| +880% | +$2.34M | ﹤0.01% | 722 |
|
|
2017
Q3 | $1.37M | Buy |
+22,533
| New | +$225K | 0.13% | 212 |
|
|
2017
Q2 | – | Sell |
-211,736
| Closed | -$1.37M | – | 841 |
|
|
2017
Q1 | $1.37M | Sell |
211,736
-208,847
| -50% | -$1.06M | 0.14% | 213 |
|
|
2016
Q4 | $1.54M | Buy |
420,583
+399,993
| +1,943% | +$1.18M | 0.2% | 155 |
|
|
2016
Q3 | $67K | Sell |
20,590
-32,422
| -61% | -$90.7K | 0.01% | 398 |
|
|
2016
Q2 | $123K | Buy |
+53,012
| New | +$177K | 0.03% | 406 |
|
Schonfeld Strategic Advisors's IMMU Position: Q4 2020 in Review
Schonfeld Strategic Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 171,114 shares — an estimated $14.6M sold.
Schonfeld Strategic Advisors first reported a position in IMMU in Q2 2016 and held it in 16 quarters. The position peaked at $14.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Schonfeld Strategic Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 171,114 Immunomedics Inc shares in Q4 2020, an estimated $14.6M.
- Schonfeld Strategic Advisors first reported a position in Immunomedics Inc in Q2 2016 and held it in 16 quarters.
- Schonfeld Strategic Advisors's Immunomedics Inc position peaked at $14.6M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.